- Global Pharma News & Resources

Global Migraine Market to 2025 - Insights, Competitive Landscape and Forecasts -

DUBLIN--(BUSINESS WIRE)--The "Migraine - Market Insights, Competitive Landscape and Market Forecast - 2026" report has been added to's offering.

This report delivers an in-depth understanding of the Migraine, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Migraine market report provides current treatment methods, emerging medical devices, market share based on treatment type, device placement and end-user, current and forecasted Migraine symptoms market size from 2018 to 2026 segmented by seven major markets. The report also covers current Migraine symptoms, medical devices used in treatment, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Migraine epidemiology segmented as the Prevalence of Migraine, Prevalent Cases of Migraine based on Severity, Gender-specific Prevalence of migraine, and Diagnosed Cases of Episodic and Chronic Migraine. The report includes the incident Migraine scenario in 7MM, covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2026.

Country Wise- Migraine Epidemiology

The epidemiology segment also provides the Migraine epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Migraine: List of Companies

  • Cefaly Technology
  • Neurolief Ltd.
  • ElectroCore, INC
  • tVNS technologies GmbH
  • Theranica Bio-Electronic Ltd.
  • eNeura, Inc.
  • WAT Medical
  • Chordate Medical
  • Soterix Medical

Migraine Market Outlook

The Migraine market outlook of the report helps build a detailed comprehension of the historic, current, and forecasted Migraine market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand of better technology.

This segment gives a thorough detail of Migraine market trend of marketed medical device by evaluating their impact based on the cost of devices, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other medical device competitors, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

Migraine Market Drivers and Barriers

The report provides insights into the market driving factors and the barriers shaping the Migraine Market. The rising prevalence and shift from pharmacological treatment, established treatment guidelines that can evolve in order to include medical devices, technological advancements and efficacious generation of medical devices.

However, a higher cost of the treatment and lack of reimbursement, lack of diagnostic tests for identification of migraine disorders and side effects associated with the neuromodulation devices can restrain the growth of this market.

Migraine Industry Trends

There have been various developments and collaborations in the field of Migraine devices. In September 2018, WAT Medical's innovative technology to treat all primary headaches, HeadaTerm, received its FDA clearance. This product, already approved by CE, HC, and now FDA, has been distributed in over 20 countries worldwide. It has now officially entered the US market as an effective treatment for migraine headaches. Also, In May 2021, Chordate Medical received CE mark approval for neuromodulation treatment of chronic migraine.

Report Highlights

  • The report covers descriptive overview of the Migraine, explaining its applications, working mechanism, etc.
  • The report provides an insight into the patient population eligible for Implantation of Cardiac monitors in the 7 MM, covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.
  • The report is a comprehensive account of marketed devices present in the Migraine market.
  • The report also reviews the detailed global historical and forecasted Migraine devices market including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the global Migraine market.

Reasons to Buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Migraine market
  • To understand the future market competition in the Migraine market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Migraine in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Migraine market
  • To understand the future market competition in the Migraine market

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 09-Dec-2021